← 產業報告目錄
Synthetic Biology Market Share & Trends Analysis Report, By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism), By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies), By Application, By End Use, By Region, and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-04頁數 165報告編號 INSIGHTACE-d399781a26
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Synthetic Biology Market worldwide was assessed at USD 17.67 Bn. Analysts project it will develop to USD 97.66 Bn by 2034, at a CAGR of 18.8% spanning 2025 to 2034.
The Synthetic Biology sector involves a rapidly advancing scientific discipline focused on repurposing organisms to give them new capabilities. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is driven by growing requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Synthetic Biology Market Snapshot
Chapter 4. Global Synthetic Biology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2021-2034
4.8. Global Synthetic Biology Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Synthetic Biology Industry Trends
Chapter 5. Synthetic Biology Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Oligonucleotide/Oligo Pools and Synthetic DNA
5.2.2. Enzymes
5.2.3. Cloning Technologies Kits
5.2.4. Xeno-Nucleic Acids
5.2.5. Chassis Organism
Chapter 6. Synthetic Biology Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share by Technology, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technologys:
6.2.1. NGS Technology
6.2.2. PCR Technology
6.2.3. Genome Editing Technology
6.2.4. Bioprocessing Technology
6.2.5. Other Technologies
Chapter 7. Synthetic Biology Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Applications:
7.2.1. Healthcare
7.2.1.1. Clinical
7.2.1.1.1. Bio/Pharmaceuticals
7.2.1.1.2. Diagnostics
7.2.1.2. Non-Clinical
7.2.2. Non-healthcare
7.2.2.1. Biotech Crops
7.2.2.2. Specialty Chemicals
7.2.2.3. Bio-fuels
7.2.2.4. Others
Chapter 8. Synthetic Biology Market Segmentation 4: By End Use, Estimates & Trend Analysis
8.1. Market Share by End Use, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Uses:
8.2.1. Biotechnology and Pharmaceutical companies
8.2.2. Academic and Research Institutes
8.2.3. Others
Chapter 9. Synthetic Biology Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Synthetic Biology Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.3. North America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.4. North America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.5. North America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.3. Europe
9.3.1. Europe Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.3. Europe Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.4. Europe Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.5. Europe Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.3. Asia Pacific Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.4. Asia Pacific Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.4.5. Asia Pacific Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.5. Latin America
9.5.1. Latin America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.3. Latin America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.4. Latin America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.5. Latin America Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.6.3. Middle East & Africa Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.6.4. Middle East & Africa Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.5. Middle East & Africa Synthetic Biology Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Bota Biosciences Inc.
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerProductance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Codexis, Inc.
10.2.3. Creative Biogene.
10.2.4. Creative Enzymes.
10.2.5. Enbiotix, Inc.
10.2.6. Illumina, Inc.
10.2.7. Merck Kgaa
10.2.8. New England Biolabs
10.2.9. Eurofins Scientific
10.2.10. Novozymes
10.2.11. Pareto Bio, Inc.
10.2.12. Scarab Genomics, Llc
10.2.13. Synthego
10.2.14. Synthetic Genomics Inc.
10.2.15. Thermo Fisher Scientific, Inc.
10.2.16. Agilent Technologies, Inc.
10.2.17. Twist Bioscience
10.2.18. BioBricks Foundation
10.2.19. DIYbio
10.2.20. Amyris
10.2.21. Cyrus Biotechnology
10.2.22. TeselaGen
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們